日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語(yǔ)Fran?ais
China
Home / China / Health

Approval sped up for pediatric drugs

By WANG XIAOYU | China Daily | Updated: 2022-06-02 09:19
Share
Share - WeChat
[Photo/VCG]

China's top drug regulator has sped up approval for pediatric medications in recent years, the National Medical Products Administration said on Tuesday.

The administration has granted pediatric urgently-needed drugs priority when it comes to reviews, and has set up green channels and designated personnel to supervise approval procedures to reduce review times as much as possible.

The development of pediatric drugs is even more contentious and time-consuming than that of drugs for adults due to obstacles and uncertainties associated with rolling out clinical trials or devising dosages.

Last year, 47 pediatric drugs or medications previously not eligible for children's use were granted market approval, among them inhalants, rotavirus vaccines and traditional Chinese medicines.

"The number of newly approved drugs was far higher than the previous year," the administration said, adding that the number of applications and approvals for pediatric drugs has been trending upward in recent years.

Between January and April, the administration completed 30 approval procedures for 21 pediatric drugs, eight of which had qualified for priority review.

"The completed workload for pediatric drug evaluation increased by 90.91 percent over the same period last year," the administration said.

In the meantime, it has been importing new pediatric drugs in urgent demand.

Some of the newly approved products include an infusion for spinal muscular atrophy and another for treating Fabry disease, a rare genetic condition that causes a buildup of fats in the bloodstream.

On May 21, a 10-year-old girl in Chongqing received Replagal, the drug for treating Fabry disease, at the Children's Hospital of Chongqing Medical University.

The drug was selected for a list of medications qualified for expedited review and approval in 2018 and granted market approval in China in August, 2020. In October last year, the medication was added onto the national drug reimbursement list.

Wang Mo, head of the nephrology department at the hospital, said during an interview with People's Daily that each round of treatment required two injections, which would have cost 6,000 yuan ($896).

With reimbursement, the girl's family only needed to cover less than 3,000 yuan, she said.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: www视频免费观看 | 91香蕉视频导航 | 亚洲高清成人欧美动作片 | 日韩精品一区二区三区视频播放 | 欧美色欧美亚洲高清在线视频 | 中文字幕精品一区二区三区精品 | 色爱综合区五月小说 | 天天久久综合网站 | av片免费| 激情av免费看 | 日韩欧美一区二区三区久久 | 欧美福利专区 | 美女被网站大全在线视频 | 久久综合一 | 特级生活片| 午夜99| 久久人人爽人人爽 | 久久影片 | 亚洲国产日韩欧美高清片a 高清视频在线播放 | 成人免费观看网欧美片 | 日本三级韩国三级欧美三级 | 好吊在线| 久久精品国产99久久6动漫亮点 | 天天干天天操天天透 | 91香焦视频 | 免费成人午夜视频 | 日韩一区精品视频 | 日韩啊v | 国产v欧美v日本v精品 | a级片免费 | 色婷婷久久久亚洲一区二区三区 | 91久久久久久久久 | 波多野结衣中文一区 | 亚洲一区二区三区四 | 色欲天天婬色婬香视频综合网 | 国产成人在线一区二区 | 成人性a激情免费视频 | 国产成人啪精品视频免费网站软件 | 久久久日韩精品一区二区 | 欧美一区免费 | 精品久久99 |